Enter your details below for more information

Invest in the Growing CBD Health and Wellbeing Sector.

  • Medicaleaf intends to generate revenue in excess of £5.34 million in this first trading year.
  • Annual predicted net profit over sales metric of plus 43%.
  • Medicaleaf is aiming for a post-raise valuation of £20 million with expectations to reach a pre-floatation valuation of £200 million in three years' time.
  • Offset over 50% of your investment with CGT and EIS relief.

Medicaleaf's vision is to be Europe's leading provider of CBD innovations for health and wellness by developing a comprehensive range of profitable lifestyle, food and beverage products.

An Estimated £135.7 Billion European Market

Disclaimer: Any person accessing the email and considering potential investment opportunities featured on the email should make their own commercial assessment of an investment opportunity after seeking the advice of an appropriately authorised or regulated financial advisor. This email should not be construed as advice or a personal recommendation to any prospective investor.